Evidence-Based. Clearly Delivered.
Evidence-Based. Clearly Delivered.
In July 2022, the Accreditation Council for Graduate Medical Education (ACGME) required sponsoring institutions to offer residents at least 6 weeks of paid medical, parental, or caregiver leave regardless of specialty. The previous July the American Board of Medical Specialties (ABMS) policy called for its member boards to allow a minimum of 6 weeks away from training for parental, caregiver, or medical leave at least once during trainees’ program.
These changes allow for more uniformity across institutions and specialties when it comes to leave policies for childbearing during training. Come 2024, the ACGME as part of its program evaluation will base accreditation on whether the new leave policies are in place. Residents will receive 100% of their salaries during the first six weeks of leave and at least one week of paid leave after return. However, training program start dates may need to be adjusted so that trainees can take leave without the specter of an extended residency looming in the background.
When viewing the issue of paid medical leave for sick workers or new parents, the US remains one of the few industrialized countries without it. The Family and Medical Leave Act (FMLA) established 12 weeks of unpaid medical leave for all US workers. Even then more 40% of workers are uncovered because they do not work for a covered employer (a private employer with more than 50 employees) or may not have worked for at least 12 months. Change on the Congressional level has stalled causing the change to come within the healthcare system.
Expanded Family Leave Policies May Ease Burden for Residents
How to implement paid family and medical leave: A toolkit for practices
Paid Maternity Leave in the United States: Associations with Maternal and Infant Health – PubMed
The ACGME’s New Paid Family and Medical Leave Policy: Just the Beginning
ACGME Answers: Resident Leave Policies
The contents of the Site, such as text, graphics, images, information obtained from The ObG Project’s licensors, and other material contained on the Site (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional legal or medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of information you have read on the Site!
If you think you may have a medical emergency, call your doctor or 911 immediately. The ObG Project does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the Site. Reliance on any information provided by The ObG Project, The ObG Project employees, others appearing on the Site at the invitation of The ObG Project, or other visitors to the Site is solely at your own risk.
The Site may contain health- or medical-related materials that are sexually explicit. If you find these materials offensive, you may not want to use our Site.
Children’s Privacy
We are committed to protecting the privacy of children. You should be aware that this Site is not intended or designed to attract children under the age of 13. We do not collect personally identifiable information from any child we reasonably believe is under the age of 13.
Exclusive Features:
Exclusive Features:
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
